Ronald Kirk Huntsman - 25 Feb 2022 Form 4 Insider Report for Vivos Therapeutics, Inc. (VVOS)

Role
Chief Executive Officer, Director
Signature
/s/ Brad Amman as attorney-in-fact for R. Kirk Huntsman
Issuer symbol
VVOS
Transactions as of
25 Feb 2022
Net transactions value
+$408,750
Form type
4
Filing time
28 Feb 2022, 17:54:57 UTC
Previous filing
14 Feb 2022
Next filing
03 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VVOS Stock Option (Right to Buy) Award $408,750 +125,000 $3.27* 125,000 25 Feb 2022 Common Stock 125,000 $3.27 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 125,000 stock options granted on February 25, 2022. One-fifth vested immediately and one-fifth vests annually on each anniversary date through February 25, 2026.